Clinical Trials Browser

Phase 2 × Astrocytoma × palbociclib × Clear all

NCT02530320 2024-11-22

Safety and Efficacy of PD0332991 (Palbociclib), a Cyclin-dependent Kinase 4 and 6 Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved

Phase 2 Completed

34 enrolled 13 charts

Astrocytoma, Oligodendroglioma

NCT01227434 2015-07-17

PD0332991

Phase 2 Terminated

23 enrolled 8 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma